← Leaderboards
Suvankar Majumdar
University Of Mississippi Med Ctr
$2,485,124
Attributed
$4,190,201
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $859.7K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,899,229 · 4
CDC$290,972 · 1
By mechanism
R01$1,774,440 · 1
R33$859,704 · 1
R61$776,011 · 1
N01$489,074 · 1
U50$290,972 · 1
Top collaborators
- Joseph F Maher5 shared
- Kimberly Ann Chapman2 shared
Most similar at University Of Mississippi Med Ctr
Same institution · by research overlap
- Joseph F Maher$887,220
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsSickle Cell AnemiaChildVariantGeneticLaboratoriesOther GeneticsCardiacNational Heart, Lung, And Blood InstituteGenesChildhoodGenetic VariantHemolysisRecruitment ActivityHealth DisparityAdultGenotypeHypokalemiaEchocardiographyEnvironmental Risk FactorCreatinineElectrocardiogramCommunitiesFerritin
Grant awards (11)
A randomized double-blind, placebo-controlled phase 2 clinical trial of intravenous citrulline for vaso-occlusive crisis in sickle cell disease$859,704
R33 · FY2025 · HL · contact PI
A randomized double-blind, placebo-controlled phase 2 clinical trial of intravenous citrulline for vaso-occlusive crisis in sickle cell disease$776,011
R61 · FY2024 · HL · contact PI
SCN5A gene and prolonged QT in sickle cell disease$352,263
R01 · FY2019 · MD
SCN5A gene and prolonged QT in sickle cell disease$352,263
R01 · FY2018 · MD
SCN5A gene and prolonged QT in sickle cell disease$352,263
R01 · FY2017 · MD
BABY HUG FOLLOW-UP STUDY II$30,646
N01 · FY2017 · HL · contact PI
SCN5A gene and prolonged QT in sickle cell disease$357,303
R01 · FY2016 · MD
SCN5A gene and prolonged QT in sickle cell disease$360,348
R01 · FY2015 · MD
BLOOD SAFETY SURVEILLANCE AMONG PERSONS WITH SICKLE CELL DISEASE IN MISSISSIPPI$142,422
U50 · FY2013 · DD · contact PI
BABY HUG FOLLOW-UP STUDY II$458,428
N01 · FY2012 · HL · contact PI
BLOOD SAFETY SURVEILLANCE AMONG PERSONS WITH SICKLE CELL DISEASE IN MISSISSIPPI$148,550
U50 · FY2012 · DD · contact PI